Devyser Diagnostics AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	19.3	-	-	-58.9	-52	-21.22
Depreciation & Amortization	28.8	27.1	27.7	13.1	8.5	6.03
Other Adjustments	-0.7	2.7	9.5	-2.4	-1.6	-2.76
Change in Receivables	-4.2	-12.5	-20.2	-15.7	-8.4	-2.27
Changes in Inventories	-2.6	-7.3	-9.4	-10.5	-3.4	-1.28
Changes in Accounts Payable	-5.7	-1.4	5.9	4.7	16.2	5.02
Operating Cash Flow	34.9	8.2	-50.7	-69.7	-40.5	-16.48
Operating Cash Flow Growth	132.67%	-	-	-	-	-
Capital Expenditures	-0.9	-	-	-11.5	-7.9	-2.2
Sale of Property, Plant & Equipment	-	0	0.1	-	-	-
Purchases of Intangible Assets	-	-68.7	-51.1	-20.5	-17.9	-6.6
Purchases of Investments	-	-	-	-	-	-1.52
Cash Acquisitions	1.4	-	-	-	-	-
Other Investing Activities	-	-0.5	-	-	1.9	-
Investing Cash Flow	-58.6	-70.7	-76.9	-32	-23.9	-10.32
Short-Term Debt Issued	-	-	-	-	-	-2.03
Net Short-Term Debt Issued (Repaid)	-	-	-	-	-	-2.03
Long-Term Debt Issued	-	-	-	-	0.7	-
Long-Term Debt Repaid	-0.1	-12	-15.4	-5.8	-4	-8.77
Net Long-Term Debt Issued (Repaid)	-0.1	-12	-15.4	-5.8	-3.3	-8.77
Issuance of Common Stock	-0.2	9.2	23.4	5.6	52.3	406.73
Net Common Stock Issued (Repurchased)	-0.2	9.2	23.4	5.6	52.3	406.73
Financing Cash Flow	3.1	-2.8	7.8	-0.2	48.9	395.93
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-	-1.7	1.3	1.3	1.4	0.17
Net Cash Flow	-15.2	-67	-118.5	-102	-15.4	369.12
Free Cash Flow	34	8.2	-50.7	-81.2	-48.4	-18.68
Free Cash Flow Growth	265.59%	-	-	-	-	-
FCF Margin	13.58%	3.27%	-23.37%	-47.96%	-38.23%	-19.98%
Free Cash Flow Per Share	2.04	0.49	-3.08	-4.76	-2.90	-1.56
Levered Free Cash Flow	34.8	-2	-52.7	-63.6	-35.9	-23.96
Unlevered Free Cash Flow	34.97	50.71	-42.21	-62.33	-31.89	-12.51